/PRNewswire/ Hemispherian AS ("Hemispherian" or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics.
Oslo-based startup Hemispherian has raised 1.4 million dollars in a seed round. The oversubscribed round was led by Meneldor, a biopharmaceutical investment
/PRNewswire/ Hemispherian AS ("Hemispherian" or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics.